Global NSAIDs for Dysmenorrhea Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2208180002 | Category: Pharma & Healthcare | Pages: 124 | Format: PDF | Published Date: September 13,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
The NSAIDs for Dysmenorrhea market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global NSAIDs for Dysmenorrhea market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The NSAIDs for Dysmenorrhea market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Hospital occupied for % of the NSAIDs for Dysmenorrhea global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Ibuprofen segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF and SI Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global NSAIDs for Dysmenorrhea market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main NSAIDs for Dysmenorrhea manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global NSAIDs for Dysmenorrhea market based on the following parameters – headquarters, production locations, products portfolio, NSAIDs for Dysmenorrhea revenue, sales, average price and gross margin, recent developments.
Evaluation and forecast the NSAIDs for Dysmenorrhea market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
NSAIDs for Dysmenorrhea market is split by Type and by Application. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
    Ibuprofen
    Celecoxib
    Ketoprofen
    Others
Market segment by Application (2017-2028; USD Million)
    Hospital
    Clinic
    Pharmacy
    Other
The key market players for global NSAIDs for Dysmenorrhea market are listed below:
    IOLCP
    Granules Biocause
    Strides Shasun
    BASF
    SI Group
    Hisoar
    Pfizer Inc
    Teva
    Mylan
    Apotex
    Lupin
    SANOFI-Aventis
    Boehringer-Ingelheim
    BEC Chemicals
    Shandong Xinhua Pharmaceutical
    Hengrui Medicine
    Hubei Biocause Heilen Pharmaceutical
    Zibo Xinhua-PERRIGO Pharmaceutical
    Zhejiang Jiuzhou
    Hubei Xunda
Region Segment (2017-2028; USD Million)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe NSAIDs for Dysmenorrhea product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NSAIDs for Dysmenorrhea, with price, sales, revenue and global market share of NSAIDs for Dysmenorrhea from 2019 to 2022.
Chapter 3, the NSAIDs for Dysmenorrhea competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs for Dysmenorrhea breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and NSAIDs for Dysmenorrhea market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs for Dysmenorrhea.
Chapter 13, 14, and 15, to describe NSAIDs for Dysmenorrhea sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 NSAIDs for Dysmenorrhea Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Ibuprofen
        1.2.3 Celecoxib
        1.2.4 Ketoprofen
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global NSAIDs for Dysmenorrhea Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Pharmacy
        1.3.5 Other
    1.4 Global NSAIDs for Dysmenorrhea Market Size & Forecast
        1.4.1 Global NSAIDs for Dysmenorrhea Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global NSAIDs for Dysmenorrhea Sales in Volume (2017-2028)
        1.4.3 Global NSAIDs for Dysmenorrhea Price (2017-2028) 
    1.5 Global NSAIDs for Dysmenorrhea Production Capacity Analysis
        1.5.1 Global NSAIDs for Dysmenorrhea Total Production Capacity (2017-2028)
        1.5.2 Global NSAIDs for Dysmenorrhea Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 NSAIDs for Dysmenorrhea Market Drivers
        1.6.2 NSAIDs for Dysmenorrhea Market Restraints
        1.6.3 NSAIDs for Dysmenorrhea Trends Analysis
2 Manufacturers Profiles
    2.1 IOLCP
        2.1.1 IOLCP Details
        2.1.2 IOLCP Major Business
        2.1.3 IOLCP NSAIDs for Dysmenorrhea Product and Services
        2.1.4 IOLCP NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Granules Biocause
        2.2.1 Granules Biocause Details
        2.2.2 Granules Biocause Major Business
        2.2.3 Granules Biocause NSAIDs for Dysmenorrhea Product and Services
        2.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Strides Shasun
        2.3.1 Strides Shasun Details
        2.3.2 Strides Shasun Major Business
        2.3.3 Strides Shasun NSAIDs for Dysmenorrhea Product and Services
        2.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 BASF
        2.4.1 BASF Details
        2.4.2 BASF Major Business
        2.4.3 BASF NSAIDs for Dysmenorrhea Product and Services
        2.4.4 BASF NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 SI Group
        2.5.1 SI Group Details
        2.5.2 SI Group Major Business
        2.5.3 SI Group NSAIDs for Dysmenorrhea Product and Services
        2.5.4 SI Group NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Hisoar
        2.6.1 Hisoar Details
        2.6.2 Hisoar Major Business
        2.6.3 Hisoar NSAIDs for Dysmenorrhea Product and Services
        2.6.4 Hisoar NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Pfizer Inc
        2.7.1 Pfizer Inc Details
        2.7.2 Pfizer Inc Major Business
        2.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Product and Services
        2.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Teva
        2.8.1 Teva Details
        2.8.2 Teva Major Business
        2.8.3 Teva NSAIDs for Dysmenorrhea Product and Services
        2.8.4 Teva NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Mylan
        2.9.1 Mylan Details
        2.9.2 Mylan Major Business
        2.9.3 Mylan NSAIDs for Dysmenorrhea Product and Services
        2.9.4 Mylan NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Apotex
        2.10.1 Apotex Details
        2.10.2 Apotex Major Business
        2.10.3 Apotex NSAIDs for Dysmenorrhea Product and Services
        2.10.4 Apotex NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Lupin
        2.11.1 Lupin Details
        2.11.2 Lupin Major Business
        2.11.3 Lupin NSAIDs for Dysmenorrhea Product and Services
        2.11.4 Lupin NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 SANOFI-Aventis
        2.12.1 SANOFI-Aventis Details
        2.12.2 SANOFI-Aventis Major Business
        2.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Product and Services
        2.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Boehringer-Ingelheim
        2.13.1 Boehringer-Ingelheim Details
        2.13.2 Boehringer-Ingelheim Major Business
        2.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product and Services
        2.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 BEC Chemicals
        2.14.1 BEC Chemicals Details
        2.14.2 BEC Chemicals Major Business
        2.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Product and Services
        2.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Shandong Xinhua Pharmaceutical
        2.15.1 Shandong Xinhua Pharmaceutical Details
        2.15.2 Shandong Xinhua Pharmaceutical Major Business
        2.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
        2.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Hengrui Medicine
        2.16.1 Hengrui Medicine Details
        2.16.2 Hengrui Medicine Major Business
        2.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Product and Services
        2.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Hubei Biocause Heilen Pharmaceutical
        2.17.1 Hubei Biocause Heilen Pharmaceutical Details
        2.17.2 Hubei Biocause Heilen Pharmaceutical Major Business
        2.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
        2.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Zibo Xinhua-PERRIGO Pharmaceutical
        2.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Details
        2.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Major Business
        2.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product and Services
        2.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Zhejiang Jiuzhou
        2.19.1 Zhejiang Jiuzhou Details
        2.19.2 Zhejiang Jiuzhou Major Business
        2.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product and Services
        2.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.20 Hubei Xunda
        2.20.1 Hubei Xunda Details
        2.20.2 Hubei Xunda Major Business
        2.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Product and Services
        2.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NSAIDs for Dysmenorrhea Breakdown Data by Manufacturer
    3.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global NSAIDs for Dysmenorrhea Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in NSAIDs for Dysmenorrhea
    3.4 Market Concentration Rate
        3.4.1 Top 3 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
        3.4.2 Top 6 NSAIDs for Dysmenorrhea Manufacturer Market Share in 2021
    3.5 Global NSAIDs for Dysmenorrhea Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and NSAIDs for Dysmenorrhea Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global NSAIDs for Dysmenorrhea Market Size by Region
        4.1.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
        4.1.2 Global NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
    4.2 North America NSAIDs for Dysmenorrhea Revenue (2017-2028)
    4.3 Europe NSAIDs for Dysmenorrhea Revenue (2017-2028)
    4.4 Asia-Pacific NSAIDs for Dysmenorrhea Revenue (2017-2028)
    4.5 South America NSAIDs for Dysmenorrhea Revenue (2017-2028)
    4.6 Middle East and Africa NSAIDs for Dysmenorrhea Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Type (2017-2028)
    5.2 Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2028)
    5.3 Global NSAIDs for Dysmenorrhea Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global NSAIDs for Dysmenorrhea Sales in Volume by Application (2017-2028)
    6.2 Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2028)
    6.3 Global NSAIDs for Dysmenorrhea Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
    7.2 North America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
    7.3 North America NSAIDs for Dysmenorrhea Market Size by Country
        7.3.1 North America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
        7.3.2 North America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
    8.2 Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
    8.3 Europe NSAIDs for Dysmenorrhea Market Size by Country
        8.3.1 Europe NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
        8.3.2 Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
    9.2 Asia-Pacific NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
    9.3 Asia-Pacific NSAIDs for Dysmenorrhea Market Size by Region
        9.3.1 Asia-Pacific NSAIDs for Dysmenorrhea Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific NSAIDs for Dysmenorrhea Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
    10.2 South America NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
    10.3 South America NSAIDs for Dysmenorrhea Market Size by Country
        10.3.1 South America NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
        10.3.2 South America NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2028)
    11.2 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2028)
    11.3 Middle East & Africa NSAIDs for Dysmenorrhea Market Size by Country
        11.3.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of NSAIDs for Dysmenorrhea and Key Manufacturers
    12.2 Manufacturing Costs Percentage of NSAIDs for Dysmenorrhea
    12.3 NSAIDs for Dysmenorrhea Production Process
    12.4 NSAIDs for Dysmenorrhea Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 NSAIDs for Dysmenorrhea Typical Distributors
    13.3 NSAIDs for Dysmenorrhea Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global NSAIDs for Dysmenorrhea Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?